ethylisopropylamiloride has been researched along with Granulocytic Leukemia, Chronic in 1 studies
ethylisopropylamiloride: structure in first source
ethylisopropylamiloride : A member of the class of pyrazines that is amiloride in which the amino substitutent of the pyrazine ring that is adjacent to the chloro substituent has been substituted by an ethyl group and by an isopropyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buyn, T | 1 |
| Dudeja, P | 1 |
| Harris, JE | 1 |
| Ou, D | 1 |
| Seed, T | 1 |
| Sawlani, D | 1 |
| Meng, J | 1 |
| Bonomi, P | 1 |
| Anderson, KM | 1 |
1 other study available for ethylisopropylamiloride and Granulocytic Leukemia, Chronic
| Article | Year |
|---|---|
A 5-lipoxygenase inhibitor at micromolar concentration raises intracellular calcium in U937 cells prior to their physiologic cell death.
Topics: Amiloride; Apoptosis; Calcium; Cell Survival; DNA; Fluoresceins; Fura-2; Humans; Hydrogen-Ion Concen | 1997 |